查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577206

到 2030 年糖尿病足溃疡治疗市场预测：按治疗类型、溃疡类型、最终用户和地区进行的全球分析

Diabetic Foot Ulcer Treatment Market Forecasts to 2030 - Global Analysis by Treatment Type (Wound Care Dressings, Wound Care Devices, Biologics, Antibiotics and Surgical Procedures), Ulcer Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球糖尿病足溃疡治疗市场规模为 90.2 亿美元，预计在预测期内复合年增长率为 8.3%，到 2030 年将达到 145.5 亿美元。

糖尿病足溃疡治疗包括各种旨在治癒糖尿病相关併发症引起的溃疡的医疗和治疗性介入。这些治疗包括创伤护理管理，例如清创和涂布高级敷料，以及使用抗生素预防感染。在严重的情况下，可能需要手术。此外，适当的足部护理和患者有关糖尿病管理的教育在预防溃疡復发方面发挥着重要作用。最终目标是加速康復、减少併发症并提高受影响个体的生活品质。

糖尿病盛行率上升

糖尿病盛行率的上升对市场产生了重大影响，增加了面临足部併发症风险的患者数量。随着糖尿病患者数量的增加，更多的人出现神经病变和血液作用不良，导致足部溃疡的发生率更高。这一趋势正在推动对先进治疗方案的需求，例如专门的创伤护理产品和治疗方法。此外，医疗保健系统被迫实施全面的管理策略来应对这些挑战，进一步推动市场成长。

治疗费用高

不断上涨的治疗成本限制了许多患者获得先进治疗的机会，并对市场产生重大影响。专门的创伤护理产品和技术的成本阻碍了及时干预，导致併发症增加和病情恶化。这些财务障碍导致治疗延误并最终影响患者的治疗结果。这阻碍了市场的成长。

技术进步

随着智慧敷料、生物活性材料和远端医疗服务等创新创伤护理解决方案的推出，技术进步正在改变市场。这些技术可提高治疗效果、促进早期癒合并改善患者监测。整合资料分析和行动医疗应用程式可促进个人化护理并改善结果和病人参与。随着医疗保健提供者采用这些技术，对先进糖尿病足溃疡治疗的需求不断增加，推动市场成长。

有限的医疗服务

获得医疗保健的机会有限阻碍了患者的及时诊断和干预，从而影响了市场。在服务不足的地区，缺乏医疗设施和专门护理可能会延误治疗并增加感染疾病和截肢等併发症的风险。这种情况会导致患者治疗效果不佳并增加长期医疗成本，凸显了改善医疗基础设施和可近性以确保有效管理糖尿病足溃疡的必要性，从而阻碍了市场成长。

COVID-19 的影响：

COVID-19 大流行导致选择性手术延迟，并因医疗机构关闭而减少患者就诊次数，从而对糖尿病足溃疡治疗市场产生了负面影响。这导致糖尿病患者的併发症增加和病情恶化。然而，这场危机也刺激了远端医疗和远距监控领域的创新，改善了治疗的可近性。

神经病变溃疡领域预计将成为预测期内最大的部分

预计预测期内神经病变溃疡领域将是最大的，因为神经病变溃疡通常是由神经损伤引起的，导致感觉下降和无法识别的损伤。神经病变溃疡的盛行率不断增加，推动了对专业治疗和高级护理解决方案的需求。随着医疗保健提供者专注于定期筛检和客製化治疗等综合管理策略，糖尿病足溃疡治疗市场持续扩大，强调了解决患者照护中神经病变病变的重要性。

医院部门预计在预测期内复合年增长率最高

医院部门预计在预测期内将出现最高的复合年增长率，因为其对包括足病学、创伤护理和糖尿病管理在内的多学科方法的关注将改善患者的治疗效果。该医院还帮助提高人们对早期疗育和预防性护理重要性的认识。此外，对先进技术和创伤护理产品的投资正在推动市场创新，并提高整个医疗系统糖尿病足溃疡治疗的可及性和效率。

比最大的地区

由于糖尿病及其併发症的盛行率不断上升，预计北美在预测期内将占据最大的市场占有率。创新的治疗方法和先进的创伤护理技术可改善患者管理并降低感染疾病和截肢的风险。这一市场成长将改善获得有效治疗的机会，最终提高患者的生活品质。医疗保健提供者的认识不断提高，进一步强调了预防保健和及时干预的重要性，从而促进了该地区糖尿病足溃疡的综合管理方法。

复合年增长率最高的地区：

由于糖尿病及相关併发症的盛行率不断上升，预计亚太地区在预测期内将呈现最高的复合年增长率。对适当足部护理的认识不断提高以及治疗技术的进步正在推动对有效治疗方法的需求。此外，旨在改善糖尿病管理和医疗基础设施的政府措施正在增加获得治疗的机会。人口老化和肥胖率上升进一步推动了这一增长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球糖尿病足溃疡治疗市场：依治疗类型

  • 创伤护理敷料
    • 泡棉敷料
    • 亲水胶体敷料
    • 藻酸盐敷料
    • 水凝胶敷料
    • 其他高级敷料
  • 创伤护理设备
    • 负压伤口治疗法（NPWT）
    • 超音波治疗仪
    • 高压氧气疗法(HBOT)
    • 电刺激设备
  • 生物製药
    • 皮肤替代品
    • 组织工程产品
  • 抗生素
    • 局部抗生素
    • 口服抗生素
  • 外科手术
    • 清创术
    • 重组
    • 植皮

第六章全球糖尿病足溃疡治疗市场：依溃疡类型

  • 神经病变溃疡
  • 缺血性溃疡
  • 神经缺血性溃疡

第七章全球糖尿病足溃疡治疗市场：依最终用户分类

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 居家照护环境
  • 其他最终用户

第八章全球糖尿病足溃疡治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第 10 章 公司概况

  • 3M Healthcare
  • Acelity LP Inc.（KCI）
  • Advanced Tissue
  • Alliqua Biomedical, Inc.
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group Plc
  • Derma Sciences Inc.
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Medline Industries, Inc.
  • Medtronic Plc
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Paul Hartmann AG
  • Smith & Nephew Plc
  • Wound Care Innovations, LLC
Product Code: SMRC27524

According to Stratistics MRC, the Global Diabetic Foot Ulcer Treatment Market is accounted for $9.02 billion in 2024 and is expected to reach $14.55 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Diabetic foot ulcer treatment encompasses a range of medical and therapeutic interventions aimed at healing ulcers resulting from diabetes-related complications. These treatments include wound care management, such as debridement and the application of advanced dressings, as well as the use of antimicrobial agents to prevent infection. In severe cases, surgical interventions may be necessary. Additionally, patient education on proper foot care and diabetes management plays a vital role in preventing ulcer recurrence. The ultimate goal is to promote healing, reduce complications, and enhance the quality of life for affected individuals.

Market Dynamics:

Driver:

Rising Diabetes Prevalence

Rising diabetes prevalence significantly impacts the market by increasing the number of patients at risk for foot complications. As diabetes cases grow, more individuals experience neuropathy and poor circulation, leading to a higher incidence of foot ulcers. This trend drives demand for advanced treatment options, including specialized wound care products and therapies. Additionally, healthcare systems are compelled to implement comprehensive management strategies to address these challenges, further fueling market growth.

Restraint:

High Treatment Costs

High treatment costs significantly impact the market by limiting access to advanced therapies for many patients. The expense associated with specialized wound care products and technologies can discourage timely intervention, leading to increased complications and worsening conditions. This financial barrier may result in delayed treatment, ultimately affecting patient outcomes. Thus, it hinders the growth opf the market.

Opportunity:

Advancements in Technology

Advancements in technology are transforming the market by introducing innovative wound care solutions, such as smart dressings, bioactive materials, and telehealth services. These technologies enhance the effectiveness of treatment, promote faster healing, and allow for better patient monitoring. The integration of data analytics and mobile health applications facilitates personalized care, improving outcomes and patient engagement. As healthcare providers increasingly adopt these technologies, the demand for advanced diabetic foot ulcer treatments grows, thus it drives the growth of the market.

Threat:

Limited Healthcare Access

Limited healthcare access impacts the market by hindering timely diagnosis and intervention for patients. In underserved regions, a lack of medical facilities and specialized care can result in delayed treatments, increasing the risk of complications like infections and amputations. This scenario leads to poorer patient outcomes and higher long-term healthcare costs, emphasizing the need for improved healthcare infrastructure and accessibility to ensure effective management of diabetic foot ulcers, thus it hampers the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic adversely affected the diabetic foot ulcer treatment market by causing delays in elective procedures and reducing patient visits to healthcare facilities due to lockdowns. This leads to increased complications and worsening conditions among diabetic patients. However, the crisis also spurred innovation in telehealth and remote monitoring, improving access to care.

The neuropathic ulcers segment is expected to be the largest during the forecast period

The neuropathic ulcers segment is expected to be the largest during the forecast period as these ulcers often result from nerve damage, leading to reduced sensation and unrecognized injuries. The growing prevalence of neuropathic ulcers drives demand for specialized treatments and advanced care solutions. As healthcare providers focus on comprehensive management strategies, including regular screening and tailored therapies, the market for diabetic foot ulcer treatments continues to expand, emphasizing the importance of addressing neuropathic conditions in patient care.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the forecast period because Increased focus on multidisciplinary approaches, including podiatry, wound care, and diabetes management, enhances patient outcomes. Hospitals are also instrumental in raising awareness about the importance of early intervention and preventative care. Moreover, their investment in advanced technologies and wound care products drives innovation in the market, improving accessibility and efficiency in treating diabetic foot ulcers across the healthcare system.

Region with largest share:

North America is projected to hold the largest market share during the forecast period as it addresses the rising incidence of diabetes and its complications. Innovative therapies and advanced wound care technologies improve patient management, reducing the risk of infections and amputations. This market's growth enhances access to effective treatments, ultimately leading to better patient quality of life. Increased awareness among healthcare providers further emphasizes the importance of preventative care and timely intervention, fostering a comprehensive approach to managing diabetic foot ulcers in the region.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period owing to rising prevalence of diabetes and related complications. Increasing awareness of proper foot care and advancements in treatment technologies are driving demand for effective therapies. Additionally, government initiatives aimed at improving diabetes management and healthcare infrastructure are enhancing access to treatments. This growth is further supported by the expanding aging population and the increasing incidence of obesity.

Key players in the market

Some of the key players in Diabetic Foot Ulcer Treatment Market include 3M Healthcare, Acelity L.P. Inc. (KCI), Advanced Tissue, Alliqua Biomedical, Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Derma Sciences Inc., Hollister Incorporated, Integra LifeSciences Corporation, Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis Inc., Osiris Therapeutics, Inc., Paul Hartmann AG, Smith & Nephew Plc and Wound Care Innovations, LLC.

Key Developments:

In August 2024, Cardinal Health expanded medical product distribution footprint in Northeast Ohio, to support its U.S. Medical Products and Distribution business.

In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

In September 2023, Cardinal Health announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.

Treatment Types Covered:

  • Wound Care Dressings
  • Wound Care Devices
  • Biologics
  • Antibiotics
  • Surgical Procedures

Ulcer Types Covered:

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuroischemic Ulcers

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Diabetic Foot Ulcer Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Wound Care Dressings
    • 5.2.1 Foam Dressings
    • 5.2.2 Hydrocolloid Dressings
    • 5.2.3 Alginate Dressings
    • 5.2.4 Hydrogel Dressings
    • 5.2.5 Other Advanced Dressings
  • 5.3 Wound Care Devices
    • 5.3.1 Negative Pressure Wound Therapy (NPWT)
    • 5.3.2 Ultrasound Therapy Devices
    • 5.3.3 Hyperbaric Oxygen Therapy (HBOT)
    • 5.3.4 Electrical Stimulation Devices
  • 5.4 Biologics
    • 5.4.1 Skin Substitutes
    • 5.4.2 Tissue-Engineered Products
  • 5.5 Antibiotics
    • 5.5.1 Topical Antibiotics
    • 5.5.2 Oral Antibiotics
  • 5.6 Surgical Procedures
    • 5.6.1 Debridement
    • 5.6.2 Revascularization
    • 5.6.3 Skin Grafting

6 Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type

  • 6.1 Introduction
  • 6.2 Neuropathic Ulcers
  • 6.3 Ischemic Ulcers
  • 6.4 Neuroischemic Ulcers

7 Global Diabetic Foot Ulcer Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Home Care Settings
  • 7.6 Other End Users

8 Global Diabetic Foot Ulcer Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Healthcare
  • 10.2 Acelity L.P. Inc. (KCI)
  • 10.3 Advanced Tissue
  • 10.4 Alliqua Biomedical, Inc.
  • 10.5 B. Braun Melsungen AG
  • 10.6 BSN Medical GmbH
  • 10.7 Cardinal Health, Inc.
  • 10.8 Coloplast A/S
  • 10.9 ConvaTec Group Plc
  • 10.10 Derma Sciences Inc.
  • 10.11 Hollister Incorporated
  • 10.12 Integra LifeSciences Corporation
  • 10.13 Medline Industries, Inc.
  • 10.14 Medtronic Plc
  • 10.15 Molnlycke Health Care AB
  • 10.16 Organogenesis Inc.
  • 10.17 Osiris Therapeutics, Inc.
  • 10.18 Paul Hartmann AG
  • 10.19 Smith & Nephew Plc
  • 10.20 Wound Care Innovations, LLC

List of Tables

  • Table 1 Global Diabetic Foot Ulcer Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Diabetic Foot Ulcer Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Dressings (2022-2030) ($MN)
  • Table 4 Global Diabetic Foot Ulcer Treatment Market Outlook, By Foam Dressings (2022-2030) ($MN)
  • Table 5 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
  • Table 6 Global Diabetic Foot Ulcer Treatment Market Outlook, By Alginate Dressings (2022-2030) ($MN)
  • Table 7 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrogel Dressings (2022-2030) ($MN)
  • Table 8 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other Advanced Dressings (2022-2030) ($MN)
  • Table 9 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Devices (2022-2030) ($MN)
  • Table 10 Global Diabetic Foot Ulcer Treatment Market Outlook, By Negative Pressure Wound Therapy (NPWT) (2022-2030) ($MN)
  • Table 11 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ultrasound Therapy Devices (2022-2030) ($MN)
  • Table 12 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hyperbaric Oxygen Therapy (HBOT) (2022-2030) ($MN)
  • Table 13 Global Diabetic Foot Ulcer Treatment Market Outlook, By Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 14 Global Diabetic Foot Ulcer Treatment Market Outlook, By Biologics (2022-2030) ($MN)
  • Table 15 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Substitutes (2022-2030) ($MN)
  • Table 16 Global Diabetic Foot Ulcer Treatment Market Outlook, By Tissue-Engineered Products (2022-2030) ($MN)
  • Table 17 Global Diabetic Foot Ulcer Treatment Market Outlook, By Antibiotics (2022-2030) ($MN)
  • Table 18 Global Diabetic Foot Ulcer Treatment Market Outlook, By Topical Antibiotics (2022-2030) ($MN)
  • Table 19 Global Diabetic Foot Ulcer Treatment Market Outlook, By Oral Antibiotics (2022-2030) ($MN)
  • Table 20 Global Diabetic Foot Ulcer Treatment Market Outlook, By Surgical Procedures (2022-2030) ($MN)
  • Table 21 Global Diabetic Foot Ulcer Treatment Market Outlook, By Debridement (2022-2030) ($MN)
  • Table 22 Global Diabetic Foot Ulcer Treatment Market Outlook, By Revascularization (2022-2030) ($MN)
  • Table 23 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Grafting (2022-2030) ($MN)
  • Table 24 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ulcer Type (2022-2030) ($MN)
  • Table 25 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuropathic Ulcers (2022-2030) ($MN)
  • Table 26 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ischemic Ulcers (2022-2030) ($MN)
  • Table 27 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuroischemic Ulcers (2022-2030) ($MN)
  • Table 28 Global Diabetic Foot Ulcer Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 30 Global Diabetic Foot Ulcer Treatment Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 31 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Diabetic Foot Ulcer Treatment Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 33 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.